Independent Variables | Breast Cancer screening RR (95% CI) | Cervical Cancer screening RR (95% CI) | Colorectal Cancer Screening RR (95% CI) |
---|---|---|---|
Time in month | 1.007 (1.003–1.012) | 1.004 (1.001–1.006) | 1.006 (1.002–1.009) |
Intervention period | |||
 Pre-period | Ref | Ref | Ref |
 Post-period | 1.019 (0.977–1.062) | 1.048 (1.020–1.076) | 1.031 (0.984–1.080) |
Clinic group designation | |||
 Comparison | Ref | Ref | Ref |
 Intervention | 1.111 (0.935–1.319) | 1.043 (0.946–1.150) | 0.863 (0.701–1.062) |
 Time*Clinic group designation | 0.996 (0.990–1.002) | 0.999 (0.996–1.002) | 0.999 (0.993–1.006) |
 Intervention period*Clinic group designation | 1.051 (0.995–1.110) | 1.050 (1.009–1.093) | 1.032 (0.971–1.097) |
 Percent Female | 0.999 (0.997–1.002) | 1.001 (1.000–1.002) | 1.001 (0.998–1.003) |
  < 138% FPL | 1.000 (0.998–1.001) | 1.000 (0.999–1.000) | 1.001 (0.999–1.002) |
 Percent English | 0.998 (0.995–1.002) | 0.998 (0.996–0.999) | 0.998 (0.995–1.001) |
 Percent Non-Hispanic White | 1.000 (0.998–1.003) | 0.999 (0.997–1.000) | 1.002 (1.000–1.004) |
State | |||
 Oregon | Ref | Ref | Ref |
 California | 1.157 (0.953–1.405) | 1.035 (0.911–1.175) | 1.194 (0.984–1.448) |
 Ohio | 0.968 (0.784–1.196) | 1.083 (0.979–1.197) | 1.087 (0.868–1.363) |